Skip to main content
. 2023 May 17;13:1147624. doi: 10.3389/fcimb.2023.1147624

Table 3.

Amphotericin B colloidal dispersion (ABCD) treatment.

Variables, (no. (%)/Median (IQR))
 Mode of infusion, (PICC) 9 (100.00)
 Duration of infusion, (h) 8 (8-10)
 Initial dose, (mg) 50 (50-50)
 Ascending time to maximum dose, (days) 5 (3-31)
 Maintenance of maximum dose, (mg) 200 (150-200)
 Treatment duration, (days) 38 (13-88)
 Cumulative dose, (mg) 5800 (2200-16900)
 Mean dose, (mg/kg/d) 3.33 (1.96-4.35)
Reasons for termination of treatment
 Switch to oral medication 4 (44.44)
 Treatment abandonment* 5 (55.56)

*there were five patients who discontinue ABCD treatment, including two cases for economic reasons, two cases because of the recurrence of primary disease, and one case of massive hemoptysis caused by fungal infection.